Sanofi SA
Company Profile
Business description
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Contact
46, avenue de la Grande Armée
Paris 75017
FRAT: +33 153774000
E: investor.relations@sanofi.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - General
Fiscal Year End
31 December 2024
Employees
87,994
Sanofi SA News & Analysis
stocks
Magnificent Seven vs. the ‘Granolas’: How does Europe’s version stack up?
stocks
10 best US blue-chip shares to buy for the long term
personal-finance
Can you achieve global diversification with multinational companies?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,020.90 | 25.20 | 0.32% |
| CAC 40 | 8,239.00 | 13.21 | 0.16% |
| DAX 40 | 18,858.98 | 142.56 | 0.76% |
| Dow JONES (US) | 39,759.61 | 201.50 | 0.51% |
| FTSE 100 | 8,443.96 | 15.83 | 0.19% |
| HKSE | 19,073.71 | 41.35 | -0.22% |
| NASDAQ | 16,643.66 | 132.48 | 0.80% |
| Nikkei 225 | 38,385.73 | 29.67 | 0.08% |
| NZX 50 Index | 11,525.88 | 92.21 | -0.79% |
| S&P 500 | 5,283.47 | 36.79 | 0.70% |
| S&P/ASX 200 | 7,753.70 | 26.90 | 0.35% |
| SSE Composite Index | 3,145.77 | 2.25 | -0.07% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.05 | 0.00 | 2.17% |
| Pantoro Ltd PNR | 0.08 | 0.00 | 1.25% |
| Core Lithium Ltd CXO | 0.15 | 0.01 | -6.25% |
| Imugene Ltd IMU | 0.07 | 0.00 | -1.41% |
| Renascor Resources Ltd RNU | 0.13 | 0.03 | 30.00% |
| Telstra Group Ltd TLS | 3.67 | 0.02 | 0.55% |
| Arafura Rare Earths Ltd ARU | 0.20 | 0.01 | 5.41% |
| South32 Ltd S32 | 3.67 | 0.05 | 1.38% |
| Karoon Energy Ltd KAR | 1.88 | 0.03 | -1.31% |
| Pilbara Minerals Ltd PLS | 3.98 | 0.01 | 0.25% |